design, setting, and participants: randomized, double-blind, placebo-controlled clinical trials of cee (estrogen-alone trial) or cee plus mpa (estrogen plus progestin trial) in community-dwelling women aged 65 to 79 years, conducted from june 1995 to july 8, 2002 (estrogen plus progestin; n = 4532), or to february 29, 2004 (estrogen-alone; n = 2947), in 39 of the 40 whi clinical centers.